Literature DB >> 27974321

Changes of choroidal structure after intravitreal aflibercept therapy for polypoidal choroidal vasculopathy.

Erina Daizumoto1, Yoshinori Mitamura1, Hiroki Sano1, Kei Akaiwa1, Masanori Niki1, Chihiro Yamanaka1, Takamasa Kinoshita1, Mariko Egawa1, Shozo Sonoda2, Taiji Sakamoto2.   

Abstract

AIMS: To quantify the changes of the choroidal structure in the enhanced depth imaging optical coherence tomographic (EDI-OCT) images after intravitreal aflibercept (IVA) injections for polypoidal choroidal vasculopathy (PCV).
METHODS: Retrospective, observational case series. Forty eyes of 40 treatment-naive patients who underwent IVA for PCV were examined by EDI-OCT before, and 3 months and 12 months after IVA. The EDI-OCT images were binarised by ImageJ software. The cross-sectional luminal and stromal areas of the inner and outer subfoveal choroid of 1500 µm width were quantified.
RESULTS: The stromal but not the luminal area of the inner choroid was significantly decreased at 3 months and 12 months after the IVA (stromal area, both p<0.001; luminal area, both p>0.050). On the other hand, the luminal but not the stromal area of the outer choroid was significantly decreased at 3 months and 12 months (luminal area, both p<0.001; stromal area, both p>0.050). The Pachychoroid Index, ratio of luminal/stromal area (L/S ratio) of the outer choroid divided by the L/S ratio of the inner choroid, was significantly decreased at 3 months and 12 months (both p<0.050). The Pachychoroid Index was increased and returned almost to the baseline level after recurrences and decreased again after successful re-treatment. The baseline Pachychoroid Index was significantly correlated with the presence of a dry macula, thinner fovea and better visual acuity at 12 months (all p<0.050).
CONCLUSION: The binarisation of the EDI-OCT images can be used to quantify the activity of PCV and to predict the prognosis after IVA. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Choroid; Imaging; Macula; Neovascularisation; Treatment Medical

Mesh:

Substances:

Year:  2017        PMID: 27974321     DOI: 10.1136/bjophthalmol-2016-309694

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Choroidal binarization analysis: clinical application.

Authors:  Sara Crisostomo; Joana Cardigos; Diogo Hipólito Fernandes; Maria Elisa Luís; Ricardo Figueiredo; Nuno Moura-Coelho; João Paulo Cunha; Luís Abegão Pinto; Joana Ferreira
Journal:  Int Ophthalmol       Date:  2019-05-28       Impact factor: 2.031

2.  Semi-automated software to measure luminal and stromal areas of choroid in optical coherence tomographic images.

Authors:  Shozo Sonoda; Taiji Sakamoto; Naoko Kakiuchi; Hideki Shiihara; Tomonori Sakoguchi; Masatoshi Tomita; Takehiro Yamashita; Eisuke Uchino
Journal:  Jpn J Ophthalmol       Date:  2017-12-21       Impact factor: 2.447

3.  Polypoidal choroidal vasculopathy in pachychoroid: combined treatment with photodynamic therapy and aflibercept.

Authors:  Maria Vadalà; Massimo Castellucci; Giulia Guarrasi; Giovanni Cillino; Vincenza Maria Elena Bonfiglio; Alessandra Casuccio; Salvatore Cillino
Journal:  Int Ophthalmol       Date:  2022-01-16       Impact factor: 2.031

4.  Choroidal Remodeling in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-month Prospective Study.

Authors:  Daniel Shu Wei Ting; Yasuo Yanagi; Rupesh Agrawal; Hwei Yee Teo; Sophia Seen; Ian Yew San Yeo; Ranjana Mathur; Choi Mun Chan; Shu Yen Lee; Edmund Yick Mun Wong; Doric Wong; Tien Yin Wong; Gemmy Chui Ming Cheung
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

5.  Changes in Choroidal Component Ratio and Circulation After Coffee Intake in Healthy Subjects.

Authors:  Daisuke Nagasato; Yoshinori Mitamura; Mariko Egawa; Fumiko Murao; Toshihiko Nagasawa; Natsumi Komori; Shozo Sonoda; Taiji Sakamoto; Hitoshi Tabuchi
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

Review 6.  Pachychoroid: current concepts on clinical features and pathogenesis.

Authors:  Veronica Castro-Navarro; Francine Behar-Cohen; Woohyok Chang; Antonia M Joussen; Timothy Y Y Lai; Rafael Navarro; Ian Pearce; Yasuo Yanagi; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-15       Impact factor: 3.117

Review 7.  Polypoidal choroidal vasculopathy treatment options: A meta-analysis.

Authors:  Tianwei Qian; Xinxin Li; Mengya Zhao; Xun Xu
Journal:  Eur J Clin Invest       Date:  2017-12-18       Impact factor: 4.686

8.  Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy.

Authors:  Shotaro Asano; Keiko Azuma; Kimiko Shimizu; Risako Yamamoto; Jinhee Lee; Hiroshi Murata; Tatsuya Inoue; Ryo Asaoka; Ryo Obata
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.